Naloxone access and pharmacy naloxone distribution not tied to more adolescent heroin, injection drug use
FDA advisers voted unanimously in favor of making the drug easier to access
Naloxone nasal spray can already be obtained without a prescription, but currently, buyers must get it from a pharmacist
Strong recommendation made against long-term opioid therapy, especially for younger age groups, those with substance use disorder
Proportion of youth aged 19 years and younger dispensed buprenorphine decreased 45 percent from 2015 to 2020
Proportion of overdose deaths did not increase in association with actions taken to ease access to buprenorphine
Letters highlighting mandate to check PMP before prescribing can increase PMP search rates and PMP account-holding rates
180-day hospitalization risk significantly increased following endocarditis for those with opioid use disorder, cocaine use disorder
About 90 and 83.9 percent of overdose deaths involved opioids and illicitly manufactured fentanyls
In interaction analyses, opioid misuse linked to increased odds of having suicide plan, suicide attempt for those with disabilities